Clinical Trial Update: The Effect of Melatonin on Gene Expression and Activity of the Sirt1 and Its Target Genes Catalase and MnSOD in Multiple Sclerosis Patients and Healthy Subjects [NA]

View source ↗

Summary

This completed trial evaluated the effect of melatonin on Sirt1 expression and activity and on its target genes catalase and MnSOD in individuals with multiple …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Melatonin (melatonin)

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Multiple Sclerosis, Oxidative Stress | NA | Status: COMPLETED